BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18785785)

  • 21. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S; Pyun MS
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
    Serrano-Martino Mdel C; Chávez-Caballero M; Valverde-Conde A; Claro RM; Pemán J; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):484-7. PubMed ID: 14572380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
    Therese KL; Bagyalakshmi R; Madhavan HN; Deepa P
    Indian J Med Microbiol; 2006 Oct; 24(4):273-9. PubMed ID: 17185846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-dermatophyte activity of Allium hirtifolium Boiss aqueous extract.
    Mahboubi M; Kazempour N
    J Mycol Med; 2015 Mar; 25(1):e10-4. PubMed ID: 25456419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of Microsporum canis isolates by DNA fingerprinting.
    Shafiee S; Khosravi AR; Ashrafi Tamai I
    Mycoses; 2014 Aug; 57(8):507-12. PubMed ID: 24635009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates.
    Moriello KA; Deboer DJ; Volk LM; Sparkes A; Robinson A
    Vet Dermatol; 2004 Jun; 15(3):175-80. PubMed ID: 15214954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first report of terbinafine resistance Microsporum canis from a cat.
    Hsiao YH; Chen C; Han HS; Kano R
    J Vet Med Sci; 2018 Jun; 80(6):898-900. PubMed ID: 29657238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tinea Capitis by Microsporum audouinii: Case Reports and Review of Published Global Literature 2000-2016.
    Brito-Santos F; Figueiredo-Carvalho MHG; Coelho RA; Sales A; Almeida-Paes R
    Mycopathologia; 2017 Dec; 182(11-12):1053-1060. PubMed ID: 28736794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antifungal activity of some essential oils against feline isolates of Microsporum canis.
    Mugnaini L; Nardoni S; Pinto L; Pistelli L; Leonardi M; Pisseri F; Mancianti F
    J Mycol Med; 2012 Jun; 22(2):179-84. PubMed ID: 23518021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal activity of Boerhavia diffusa against some dermatophytic species of Microsporum.
    Agrawal A; Srivastava S; Srivastava MM
    Hindustan Antibiot Bull; 2003 Feb-2004 Nov; 45-46(1-4):1-4. PubMed ID: 16281821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidermatophytic activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols].
    Zhang DZ; Zhou TS; Wu YJ; Liu CM; Ma MC; Feng XT
    Yao Xue Xue Bao; 1997 Dec; 32(12):943-9. PubMed ID: 11596195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance to azolic compounds in clinical Trichophyton spp. strains].
    Méndez-Tovar LJ; Manzano-Gayosso P; Velásquez-Hernández V; Millan-Chiu B; Hernández-Hernández F; Mondragón-González R; López-Martínez R
    Rev Iberoam Micol; 2007 Dec; 24(4):320-2. PubMed ID: 18095769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.
    Biancalana FS; Telles PF; Lyra L; Schreiber AZ
    Mycoses; 2008 Jul; 51(4):313-7. PubMed ID: 18422920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of antifungal activity of polyenzyme preparation Candidaseb using in vitro methods.
    Joshi A; Deshpande S; Dohe V; Risbud S; Bharadwaj R
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):10-3. PubMed ID: 19957538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
    Chadeganipour M; Nilipour S; Havaei A
    Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Microsporum canis arthrospores to a mixture of chemically defined essential oils: a perspective for environmental decontamination.
    Nardoni S; Tortorano A; Mugnaini L; Profili G; Pistelli L; Giovanelli S; Pisseri F; Papini R; Mancianti F
    Z Naturforsch C J Biosci; 2015; 70(1-2):15-24. PubMed ID: 25854840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis.
    Kano R; Hsiao YH; Han HS; Chen C; Hasegawa A; Kamata H
    Mycopathologia; 2018 Jun; 183(3):623-627. PubMed ID: 29340910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANTIFUNGAL ACTIVITY OF Cymbopogon nardus (L.) Rendle (CITRONELLA) AGAINST Microsporum canis FROM ANIMALS AND HOME ENVIRONMENT.
    Capoci IR; Cunha MM; Bonfim-Mendonça Pde S; Ghiraldi-Lopes LD; Baeza LC; Kioshima ES; Svidzinski TI
    Rev Inst Med Trop Sao Paulo; 2015 Dec; 57(6):509-11. PubMed ID: 27049705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.
    Macura AB
    Int J Dermatol; 1993 Jul; 32(7):533-6. PubMed ID: 8340195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.